Movement Disorders · 2002 · 30 citations · 8 references
MedicineNeurologyOncologyChemotherapyNeuro-oncologyOncology PharmacotherapyParkinson DiseaseParkinsonian DisordersParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease Treatment
Parkinsonism is a rare neurological complication of cancer treatment. Although individual case reports of this syndrome have been reported, the clinical features and prevalence of this syndrome are unknown. We present 3 patients, encountered over 6 months at one institution, who developed parkinsonism after treatment with various chemotherapeutic agents. Parkinsonism was severe in 2 patients, affecting postural reflexes, speech, and swallowing. All 3 patients responded dramatically to treatment with levodopa, and parkinsonism spontaneously improved or remitted over months. This unusual complication of cancer therapy is treatable and may be underappreciated.
8
Methotrexate and central nervous system toxicity.
Abelson Ht · PubMed · 1978 · 73 citations
Parkisonism induced by high‐dose cytosine arabinoside
F. Antonio Luque, John B. Selhorst, Paul J. Petruska · Movement Disorders · 1987 · 36 citations
Medicine, Neurology, Pharmacology +11